Compounds > 3,4-dihydroxyphenylacetic acid

3,4-dihydroxyphenylacetic acid and octanoic acid

3,4-dihydroxyphenylacetic acid has been researched along with octanoic acid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Joniec-Maciejak, I; Maciejak, P; Mirowska-Guzel, D; Płaźnik, A; Sobolewska, A; Szyndler, J; Turzyńska, D; Wawer, A	1

Other Studies

1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and octanoic acid

Article	Year
Octanoic acid prevents reduction of striatal dopamine in the MPTP mouse model of Parkinson's disease. Pharmacological reports : PR, 2018, Volume: 70, Issue:5 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Caprylates; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Mice; Neuroprotective Agents; Parkinson Disease; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphoenolpyruvate Carboxykinase (GTP)	2018

Article

Year

Octanoic acid prevents reduction of striatal dopamine in the MPTP mouse model of Parkinson's disease.

Pharmacological reports : PR, 2018, Volume: 70, Issue:5

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Caprylates; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Mice; Neuroprotective Agents; Parkinson Disease; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphoenolpyruvate Carboxykinase (GTP)

2018